China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Application Study of Physical Therapy Combined with Intra-articular Injection o... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Laparoscopic exploration and stone removal of common bile duct'. The following are the o... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Cross-Sectional Study on Differences in Specific Biomarkers Among Postmenopausal Women w... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Survey on Preferences of Home Rehabilitation Services among Elderly in Chongqing'. The f... Read More
China, Oct. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Comparative Study of Ultrasound-Guided Liposomal Bupivacaine Paravertebral Block versu... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wit... Read More
Singapore, Oct. 7 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wit... Read More